Ylva Ginsberg

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. pmc Attention Deficit Hyperactivity Disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder
    Ylva Ginsberg
    Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden
    BMC Psychiatry 10:112. 2010
  2. doi request reprint Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension
    Ylva Ginsberg
    Department of Clinical Neuroscience, Division of Psychiatry and Center of Neurodevelopmental Disorders, Karolinska Institutet, Stockholm, Sweden
    Br J Psychiatry 200:68-73. 2012
  3. pmc Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate
    Ylva Ginsberg
    Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden
    Eur Arch Psychiatry Clin Neurosci 262:705-24. 2012

Detail Information

Publications3

  1. pmc Attention Deficit Hyperactivity Disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder
    Ylva Ginsberg
    Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden
    BMC Psychiatry 10:112. 2010
    ..We estimated the prevalence of ADHD among longer-term prison inmates, described symptoms and cognitive functioning, and compared findings with ADHD among psychiatric outpatients and healthy controls...
  2. doi request reprint Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension
    Ylva Ginsberg
    Department of Clinical Neuroscience, Division of Psychiatry and Center of Neurodevelopmental Disorders, Karolinska Institutet, Stockholm, Sweden
    Br J Psychiatry 200:68-73. 2012
    ..Attention-deficit hyperactivity disorder (ADHD) is highly prevalent in prison inmates, but pharmacological treatment has not yet been evaluated in this group...
  3. pmc Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate
    Ylva Ginsberg
    Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden
    Eur Arch Psychiatry Clin Neurosci 262:705-24. 2012
    ..Finally, investigators' and self-ratings of ADHD symptoms associated significantly at baseline with increasing convergence over time...